invIOs
Company Details
Status: Private
Employees: 11-50
Location:
Vienna, Austria
Type:
sample
Technology:
sample
sample
sample
sample
sample
About: invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer.
We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials.
We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics.
Our highly motivated team of 35 people has deep expertise across the biotechnology value chain, with in-house expertise in R&D, clinical development, CMC, IP, scouting and more.
All of our approaches are designed with a single goal: To transform patients' lives, so that cancer doesn’t.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
invIOs | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.